The skin and mucosal membranes (GI tract, oronasal cavity, pulmonary tract, and the vagina) are dynamic and complex layers involved in the absorption and secretion of a wide range of molecules and is an important target for vaccine development and the treatment of diseases such as cancer, sexually transmitted infections, and pulmonary disorders. Despite advancements made in the field of transdermal and mucosal delivery, there are still challenges and barriers to developing transdermal and mucosal therapeutics. This focus group will provide a forum for discussion in the field of transdermal and mucosal delivery, the challenges/barriers encountered, and novel strategies to overcome these obstacles to develop a successful therapeutic. The “Transdermal and Mucosal Delivery (TMD)” Focus Group (FG) will also provide a dynamic platform for like-minded professionals (whether you are new to the field or an established scientist) from academia, industry, and the government to efficiently exchange ideas related to cutting edge science and technology in the field.
The members of the Focus Group are expected to be paid members of the Controlled Release Society independent of their membership category.